vs
KEWAUNEE SCIENTIFIC CORP（KEQU）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是KEWAUNEE SCIENTIFIC CORP的1.1倍（$75.5M vs $70.1M），KEWAUNEE SCIENTIFIC CORP同比增速更快（46.8% vs 27.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-5.8M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 22.4%）
基沃尼科学公司是实验室家具、通风柜及一体化实验室基础设施解决方案的专业供应商，服务覆盖制药、生物技术、学术研究、医疗健康、工业研发等领域，核心市场为北美地区，同时正在稳步拓展全球客户网络。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
KEQU vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$70.1M
营收增速更快
KEQU
高出19.0%
27.7%
自由现金流更多
PBYI
多$20.2M
$-5.8M
两年增速更快
PBYI
近两年复合增速
22.4%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $70.1M | $75.5M |
| 净利润 | $2.4M | — |
| 毛利率 | 28.1% | 69.3% |
| 营业利润率 | 5.9% | 22.7% |
| 净利率 | 3.5% | — |
| 营收同比 | 46.8% | 27.7% |
| 净利润同比 | -18.7% | — |
| 每股收益（稀释后） | $0.82 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KEQUPBYI
| Q4 25 | $70.1M | $75.5M | ||
| Q3 25 | $71.1M | $54.5M | ||
| Q2 25 | $77.1M | $52.4M | ||
| Q1 25 | $67.2M | $46.0M | ||
| Q4 24 | $47.8M | $59.1M | ||
| Q3 24 | $48.4M | $80.5M | ||
| Q2 24 | $56.7M | $47.1M | ||
| Q1 24 | $46.8M | $43.8M |
净利润KEQUPBYI
| Q4 25 | $2.4M | — | ||
| Q3 25 | $3.1M | $8.8M | ||
| Q2 25 | $4.8M | $5.9M | ||
| Q1 25 | $1.4M | $3.0M | ||
| Q4 24 | $3.0M | — | ||
| Q3 24 | $2.2M | $20.3M | ||
| Q2 24 | $11.0M | $-4.5M | ||
| Q1 24 | $2.5M | $-4.8M |
毛利率KEQUPBYI
| Q4 25 | 28.1% | 69.3% | ||
| Q3 25 | 29.4% | 77.7% | ||
| Q2 25 | 31.2% | 76.5% | ||
| Q1 25 | 27.4% | 77.1% | ||
| Q4 24 | 29.2% | 76.4% | ||
| Q3 24 | 25.8% | 63.9% | ||
| Q2 24 | 25.8% | 77.4% | ||
| Q1 24 | 25.7% | 75.5% |
营业利润率KEQUPBYI
| Q4 25 | 5.9% | 22.7% | ||
| Q3 25 | 6.8% | 17.6% | ||
| Q2 25 | 11.0% | 12.7% | ||
| Q1 25 | 3.3% | 8.7% | ||
| Q4 24 | 9.3% | 22.6% | ||
| Q3 24 | 5.3% | 27.4% | ||
| Q2 24 | 9.8% | -4.6% | ||
| Q1 24 | 8.1% | -5.3% |
净利率KEQUPBYI
| Q4 25 | 3.5% | — | ||
| Q3 25 | 4.3% | 16.2% | ||
| Q2 25 | 6.3% | 11.2% | ||
| Q1 25 | 2.0% | 6.5% | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 4.5% | 25.2% | ||
| Q2 24 | 19.4% | -9.6% | ||
| Q1 24 | 5.4% | -11.0% |
每股收益（稀释后）KEQUPBYI
| Q4 25 | $0.82 | $0.26 | ||
| Q3 25 | $1.04 | $0.17 | ||
| Q2 25 | $1.63 | $0.12 | ||
| Q1 25 | $0.45 | $0.06 | ||
| Q4 24 | $1.01 | $0.40 | ||
| Q3 24 | $0.74 | $0.41 | ||
| Q2 24 | $3.74 | $-0.09 | ||
| Q1 24 | $0.85 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.6M | $97.5M |
| 总债务越低越好 | $35.3M | $22.7M |
| 股东权益账面价值 | $69.9M | $130.3M |
| 总资产 | $189.1M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.50× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资KEQUPBYI
| Q4 25 | $12.6M | $97.5M | ||
| Q3 25 | $19.5M | $94.4M | ||
| Q2 25 | $14.9M | $96.0M | ||
| Q1 25 | $9.5M | $93.2M | ||
| Q4 24 | $26.0M | $101.0M | ||
| Q3 24 | $24.2M | $96.7M | ||
| Q2 24 | $23.3M | $96.8M | ||
| Q1 24 | $21.3M | $107.2M |
总债务KEQUPBYI
| Q4 25 | $35.3M | $22.7M | ||
| Q3 25 | $37.4M | $34.0M | ||
| Q2 25 | $37.7M | $45.3M | ||
| Q1 25 | $38.0M | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益KEQUPBYI
| Q4 25 | $69.9M | $130.3M | ||
| Q3 25 | $67.1M | $115.3M | ||
| Q2 25 | $64.5M | $104.7M | ||
| Q1 25 | $60.8M | $97.1M | ||
| Q4 24 | $59.3M | $92.1M | ||
| Q3 24 | $56.0M | $71.1M | ||
| Q2 24 | $54.8M | $48.5M | ||
| Q1 24 | $44.1M | $51.0M |
总资产KEQUPBYI
| Q4 25 | $189.1M | $216.3M | ||
| Q3 25 | $193.5M | $202.9M | ||
| Q2 25 | $194.7M | $194.9M | ||
| Q1 25 | $189.1M | $196.2M | ||
| Q4 24 | $134.5M | $213.3M | ||
| Q3 24 | $132.0M | $220.7M | ||
| Q2 24 | $134.8M | $205.0M | ||
| Q1 24 | $126.3M | $214.1M |
负债/权益比KEQUPBYI
| Q4 25 | 0.50× | 0.17× | ||
| Q3 25 | 0.56× | 0.30× | ||
| Q2 25 | 0.58× | 0.43× | ||
| Q1 25 | 0.62× | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-5.8M | $14.4M |
| 自由现金流率自由现金流/营收 | -8.3% | 19.1% |
| 资本支出强度资本支出/营收 | 2.2% | 0.0% |
| 现金转化率经营现金流/净利润 | -1.74× | — |
| 过去12个月自由现金流最近4个季度 | $5.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流KEQUPBYI
| Q4 25 | $-4.3M | $14.4M | ||
| Q3 25 | $5.8M | $9.7M | ||
| Q2 25 | $9.4M | $14.1M | ||
| Q1 25 | $-2.3M | $3.6M | ||
| Q4 24 | $8.4M | $15.6M | ||
| Q3 24 | $-794.0K | $11.0M | ||
| Q2 24 | $1.1M | $1.0M | ||
| Q1 24 | $9.5M | $11.2M |
自由现金流KEQUPBYI
| Q4 25 | $-5.8M | $14.4M | ||
| Q3 25 | $5.0M | $9.7M | ||
| Q2 25 | $8.9M | $14.1M | ||
| Q1 25 | $-3.0M | $3.6M | ||
| Q4 24 | $7.8M | $15.6M | ||
| Q3 24 | $-1.1M | $11.0M | ||
| Q2 24 | $166.0K | $1.0M | ||
| Q1 24 | $9.0M | — |
自由现金流率KEQUPBYI
| Q4 25 | -8.3% | 19.1% | ||
| Q3 25 | 7.1% | 17.7% | ||
| Q2 25 | 11.5% | 26.8% | ||
| Q1 25 | -4.4% | 7.7% | ||
| Q4 24 | 16.2% | 26.4% | ||
| Q3 24 | -2.2% | 13.7% | ||
| Q2 24 | 0.3% | 2.1% | ||
| Q1 24 | 19.3% | — |
资本支出强度KEQUPBYI
| Q4 25 | 2.2% | 0.0% | ||
| Q3 25 | 1.1% | 0.0% | ||
| Q2 25 | 0.7% | 0.0% | ||
| Q1 25 | 1.0% | 0.1% | ||
| Q4 24 | 1.4% | 0.0% | ||
| Q3 24 | 0.6% | 0.0% | ||
| Q2 24 | 1.7% | 0.0% | ||
| Q1 24 | 1.0% | 0.0% |
现金转化率KEQUPBYI
| Q4 25 | -1.74× | — | ||
| Q3 25 | 1.87× | 1.10× | ||
| Q2 25 | 1.94× | 2.41× | ||
| Q1 25 | -1.67× | 1.21× | ||
| Q4 24 | 2.80× | — | ||
| Q3 24 | -0.36× | 0.54× | ||
| Q2 24 | 0.10× | — | ||
| Q1 24 | 3.77× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KEQU
| Transferred Over Time | $32.9M | 47% |
| Transferred At Point In Time | $22.3M | 32% |
| Other | $14.9M | 21% |
PBYI
暂无分部数据
